Axogen (AXGN) EBITDA Margin (QoQ) (2010 - 2026)
Axogen (AXGN) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.79 Bn | 195.19 Bn | 7.27 Bn |
| 2 | Stryker | 125.96 Bn | 122.49 Bn | 4.50 Bn |
| 3 | Medtronic | 118.43 Bn | 109.21 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.13 Bn | 72.59 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.63 Bn | 47.38 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.17 Bn | 22.85 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Axogen | 2.51 Bn | 2.39 Bn | 50.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 152.00 |
| Mar 31, 2026 | 1,170.00 |
| Dec 31, 2025 | -1,950.00 |
| Sep 30, 2025 | 23.00 |
| Jun 30, 2025 | 637.00 |
| Mar 31, 2025 | -750.00 |
| Dec 31, 2024 | 473.00 |
| Sep 30, 2024 | 24.00 |
| Jun 30, 2024 | 1,013.00 |
| Mar 31, 2024 | -358.00 |
| Dec 31, 2023 | 231.00 |
| Sep 30, 2023 | 834.00 |
| Jun 30, 2023 | 193.00 |
| Mar 31, 2023 | -452.00 |
| Dec 31, 2022 | -237.00 |
| Sep 30, 2022 | 986.00 |
| Jun 30, 2022 | 1,351.00 |
| Mar 31, 2022 | -1,953.00 |
| Dec 31, 2021 | 446.00 |
| Sep 30, 2021 | -13.00 |